R.A. Session II

Insider Reports History

Entity
Individual
Location
C/O Avexis, Inc., 2275 Half Day Road, Suite 200, Bannockburn, IL
Signature
/s/ R.A. Session II
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by R.A. Session II:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 8.87M $14.5M $1.63 Jul 13, 2023 Direct
Taysha Gene Therapies, Inc. 10%+ Owner Common Stock 141K $230K $1.63 Jul 12, 2023 Indirect

Insider Reports Filed by R.A. Session II

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TSHA Taysha Gene Therapies, Inc. Jul 12, 2023 2 -$60.8K 4 Jul 14, 2023 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Jun 22, 2023 2 -$20.1K 4 Jun 26, 2023 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Jun 20, 2023 2 -$308K 4 Jun 22, 2023 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Mar 6, 2023 2 $0 4 Mar 8, 2023 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Nov 10, 2022 1 $0 4 Dec 23, 2022 Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Feb 23, 2022 1 $0 4 Feb 25, 2022 President and CEO, Director, 10%+ Owner
TSHA Taysha Gene Therapies, Inc. Nov 23, 2021 2 $529K 4 Dec 8, 2021 President and CEO, Director, 10%+ Owner